Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurosci ; 13(11): 2171-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11422459

ABSTRACT

Generalized epilepsy with febrile seizures-plus (GEFS+) is a benign Mendelian syndrome characterized by childhood-onset febrile and afebrile seizures. Three point mutations within two voltage-gated sodium channel genes have been identified so far: in GEFS+ type 1 a mutation in the beta1-subunit gene SCN1B, and in GEFS+ type 2 two mutations within the neuronal alpha-subunit gene SCN1A. Functional expression of the SCN1B and one of the SCN1A mutations revealed defects in fast channel inactivation which are in line with previous findings on myotonia causing mutations in SCN4A, the skeletal muscle sodium channel alpha-subunit gene, all showing an impaired fast inactivation. We now studied the second GEFS+ mutation (T875M in SCN1A), using the highly homologous SCN4A gene (mutation T685M). Unexpectedly, the experiments revealed a pronounced enhancement of both fast and slow inactivation and a defect of channel activation for T685M compared to wild-type channels. Steady-state fast and slow inactivation curves were shifted in the hyperpolarizing direction, entry into slow inactivation was threefold accelerated, recovery from slow inactivation was slowed by threefold and the time course of activation was slightly but significantly accelerated. In contrast to other disease-causing mutations in SCN1A, SCN1B and SCN4A, the only mechanism that could explain hyperexcitability of the cell membrane would be the acceleration of activation. Because the enhancement of slow inactivation was the most obvious alteration in gating found for T685M, this might be the disease-causing mechanism for that mutation. In this case, the occurrence of epileptic seizures could be explained by a decrease of excitability of inhibitory neurons.


Subject(s)
Cerebral Cortex/metabolism , Epilepsy, Generalized/genetics , Membrane Potentials/genetics , Mutation/physiology , Neural Inhibition/drug effects , Neurons/metabolism , Sodium Channels/genetics , Animals , Cells, Cultured/cytology , Cells, Cultured/metabolism , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Epilepsy, Generalized/metabolism , Epilepsy, Generalized/physiopathology , Gene Expression Regulation/physiology , Molecular Sequence Data , NAV1.1 Voltage-Gated Sodium Channel , NAV1.4 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/pathology , Sequence Homology, Amino Acid , Sodium Channels/metabolism , Time Factors
2.
Neurosci Lett ; 306(3): 173-6, 2001 Jun 29.
Article in English | MEDLINE | ID: mdl-11406323

ABSTRACT

Fast and slow inactivation (FI, SI) of the voltage-gated Na+ channel are two kinetically distinct and structurally dissociated processes. The voltage sensor IV/S4 and the intracellular IV/S4-S5 loop have been shown to play an important role in FI mediating the coupling between activation and inactivation. Two mutations in IV/S4-S5 of the human muscle Na+ channel, L1482C/A, disrupt FI by inducing a persistent Na+ current, shifting steady-state inactivation in the depolarizing direction and accelerating its recovery. These effects were more pronounced for L1482A. In contrast, SI of L1482C/A channels was enhanced showing a more complete SI and a 3-fold slowing of its recovery. Effects on SI were more pronounced for L1482C. The results indicate an important role of the IV/S4-S5 loop not only in FI but also in SI of the Na+ channel.


Subject(s)
Ion Channel Gating/genetics , Muscle, Skeletal/metabolism , Sodium Channels/genetics , Sodium Channels/metabolism , Humans , Membrane Potentials/physiology , Mutagenesis, Site-Directed/physiology , Myotonia/genetics , Myotonia/metabolism , Paralysis/genetics , Paralysis/metabolism , Patch-Clamp Techniques
3.
J Physiol ; 529 Pt 3: 533-9, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11118488

ABSTRACT

Generalized epilepsy with febrile seizures plus (GEFS+) is a benign epileptic syndrome of humans. It is characterized by febrile and afebrile generalized seizures that occur predominantly in childhood and respond well to standard antiepileptic therapy. A mutation in the b1-subunit of the voltage-gated sodium channel, linked to chromosome 19q13 (GEFS+ type 1) has been found in one family. For four other families, linkage was found to chromosome 2q21-33 (GEFS+ type 2) where three genes encoding neuronal sodium channel a-subunits are located (SCN1-3A). Recently, the first two mutations were identified in SCN1A. We introduced one of these mutations, which is highly conserved to SCN1A, into the cDNA of the gene SCN4A encoding the a-subunit of the human skeletal muscle sodium channel (hSkm1). The mutation is located in the S4 voltage sensor of domain IV, predicting substitution of histidine for the fifth of eight arginines (R1460H in hSkm1). Functional studies were performed by expressing the a-subunit alone in the mammalian tsA201 cell line using the whole-cell patch clamp technique. Compared to wild-type (WT), mutant R1460H channels showed small defects in fast inactivation. The time course of inactivation was slightly (1.5-fold) slowed and its voltage dependence reduced, and recovery from inactivation was accelerated 3-fold. However, there was no increase in persistent sodium current as observed for SCN4A mutations causing myotonia or periodic paralysis. The activation time course of R1460H channels was slightly accelerated. Slow inactivation was slightly but significantly stabilized, confirming the importance of this region for slow inactivation. The combination of activation and fast inactivation defects can explain the occurrence of epileptic seizures, but the effects were much more subtle than the inactivation defects described previously for mutations in SCN4A causing disease in skeletal muscle. Hence, with regard to pathological excitability, our results suggest a greater vulnerability of the central nervous system compared to muscle tissue.


Subject(s)
Epilepsy/genetics , Mutation/physiology , Sodium Channels/genetics , Sodium Channels/physiology , Amino Acid Sequence/genetics , Amino Acid Substitution , Conserved Sequence/genetics , Electrophysiology , Humans , Hydrogen-Ion Concentration , Molecular Sequence Data , NAV1.1 Voltage-Gated Sodium Channel , NAV1.4 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/genetics , Patch-Clamp Techniques , Reaction Time/physiology , Time Factors
4.
J Colloid Interface Sci ; 220(2): 224-228, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10607437

ABSTRACT

Low-frequencyanomalous electro-optic behavior of colloidal systems (sign reversal and deviations from Kerr low) is considered in the light of electrically induced acoustic modes. The latter were recently detected and investigated in samples of isotropic spherical particles. Their linear dependence on field intensity explains the low-field "permanent dipole" behavior of charged colloids. The coupling of anisotropy and density fluctuations results in the complicated frequency curves of the electro-optic responses of anisometric particles. Copyright 1999 Academic Press.

5.
Ann Neurol ; 46(3): 305-12, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10482260

ABSTRACT

Benign familial neonatal convulsions (BFNC) is a rare dominantly inherited epileptic syndrome characterized by frequent brief seizures within the first days of life. The disease is caused by mutations in one of two recently identified voltage-gated potassium channel genes, KCNQ2 or KCNQ3. Here, we describe a four-generation BFNC family carrying a novel mutation within the distal, unconserved C-terminal domain of KCNQ2, a 1-bp deletion, 2513delG, in codon 838 predicting substitution of the last seven and extension by another 56 amino acids. Three family members suffering from febrile but not from neonatal convulsions do not carry the mutation, confirming that febrile convulsions and BFNC are of different pathogenesis. Functional expression of the mutant channel in Xenopus oocytes revealed a reduction of the potassium current to 5% of the wild-type current, but the voltage sensitivity and kinetics were not significantly changed. To find out whether the loss of the last seven amino acids or the C-terminal extension because of 2513delG causes the phenotype, a second, artificial mutation was constructed yielding a stop codon at position 838. This truncation increased the potassium current by twofold compared with the wild type, indicating that the pathological extension produces the phenotype, and suggesting an important role of the distal, unconserved C-terminal domain of this channel. Our results indicate that BFNC is caused by a decreased potassium current impairing repolarization of the neuronal cell membrane, which results in hyperexcitability of the central nervous system.


Subject(s)
Potassium Channels/genetics , Potassium Channels/physiology , Seizures/genetics , Amino Acid Sequence , Base Sequence , Electrophysiology , Female , Humans , Infant, Newborn , KCNQ2 Potassium Channel , Male , Molecular Sequence Data , Mutation/genetics , Pedigree , Polymerase Chain Reaction , Potassium Channels, Voltage-Gated , Seizures/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...